Research Article

ACTH Treatment for Management of Nephrotic Syndrome: A Systematic Review and Reappraisal

Table 9

Summary of studies on ACTH in IgA nephropathy.

StudyNStudy protocolMean initial lab valuesStudy outcomeComplications

IgA nephropathy (IgAN)

Bomback et al. [5]1Acthar gel: 40 units twice per week for 8 monthsProteinuria: 4952 mg/dayProteinuria: 42 mg/day
1 complete response
None
Bomback et al. [4]5Acthar gel: 40 units twice per week for 2 weeks then 80 units twice per week for 6 monthsSCr: 0.8–2.7 mg/dl
SrA: 3.7–4.3 g/dl
UPCR: 0.61–1.95 g/g
SCr: 0.8–2.1 mg/dl
SrA: 4.1–4.5 g/dl
UPCR: 0.21–1.22 g/g
1 complete response
1 partial response
n = 1 weight gain, cushingoid facies, increased blood pressure; Withdrawn due to worsening kidney function
Madan et al. [2]5Acthar gel: 80 units twice weekly for 6 monthsSCr: 1.0–2.8 mg/dl
SrA: 3.0–2.0 g/dl
Proteinuria 2500–9306 mg/d (4268 ± 2931 mg/d)
SCr: 1.0–1.5 mg/dl
SrA: 3.6–4.2 g/dl
Proteinuria: 800–2360 mg/d (1416 ± 654 mg/d)
67.3% reduction in proteinuria
2 partial remissions
1 early termination
(n = 1) weight gain
(n = 1) hypertension
Khastgir et al. [6]5Acthar gel: 80 units twice weekly for 6 monthsN/A2 partial remissions
36.4% proteinuria reduction
1 early termination due to hypertension and weight gain
Zand et al. [24]19Acthar gel: 80 units twice weekly for 6 monthsSCr: 1.40 ± 0.49 mg/dl
SrA: 3.79 ± 0.54 g/dl
24 hr UP: 2635 (1230–5243) mg
SCr: 1.55 ± 0.64 mg/dl
SrA: 3.93 ± 0.39 g/dl
24 hr UP: 1274
(344–6228) mg
8 partial remissions
6 infections: 2 viral, 2 sinusitis, 1 pneumonia, 1 otitis media

SCr, serum creatinine; SrA, serum albumin; UP, urine protein; UPCR, urine protein creatinine ratio.